Drug Shortage Report for DEPO-PROVERA
Report ID | 79397 |
Drug Identification Number | 00585092 |
Brand name | DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML |
Common or Proper name | Depo-Provera |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MEDROXYPROGESTERONE ACETATE |
Strength(s) | 150MG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR |
Packaging size | 5x1ml |
ATC code | G03AC |
ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-03-25 |
Estimated end date | 2019-04-16 |
Actual end date | 2019-04-16 |
Shortage status | Resolved |
Updated date | 2019-04-17 |
Company comments | Other presentation available: Depo-Provera 150mg/ml 1x1ml |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2019-04-17 | English | Compare |
v7 | 2019-04-16 | French | Compare |
v6 | 2019-04-16 | English | Compare |
v5 | 2019-04-11 | French | Compare |
v4 | 2019-04-11 | English | Compare |
v3 | 2019-03-26 | English | Compare |
v2 | 2019-03-25 | French | Compare |
v1 | 2019-03-25 | English | Compare |
Showing 1 to 8 of 8